Delfina delivers an AI-powered maternal health platform that integrates predictive analytics, EHR workflows and patient engagement to identify risks early and guide timely interventions across prenatal and postpartum care. Its models were developed with diverse population data and leading obstetricians, and are able to surface risks such as hypertensive disorders and gestational diabetes, reducing preventable complications and high-cost events like neonatal intensive care unit admissions. Clinicians access real-time risk dashboards and streamlined workflows while expectant mothers use a companion app for tracking, education and continuous connection to care teams. The company saw a $17 million Series A in January 2025, along with partnerships with BCBS New Mexico and BCBS Illinois and collaboration with Lone Star Circle of Care. Honors include an industry award for “Best Maternal Health Platform” earned in spring 2025, among others.
